Compare NAII & VRAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NAII | VRAR |
|---|---|---|
| Founded | 1980 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.2M | 21.9M |
| IPO Year | 1987 | 2021 |
| Metric | NAII | VRAR |
|---|---|---|
| Price | $3.20 | $0.80 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $2.62 |
| AVG Volume (30 Days) | 16.2K | ★ 129.0K |
| Earning Date | 02-13-2026 | 02-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $134,440,000.00 | $9,488,209.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $72.00 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 19.00 | 16.60 |
| 52 Week Low | $2.57 | $0.77 |
| 52 Week High | $4.40 | $3.85 |
| Indicator | NAII | VRAR |
|---|---|---|
| Relative Strength Index (RSI) | 56.17 | 31.10 |
| Support Level | $3.14 | $0.77 |
| Resistance Level | $3.46 | $1.10 |
| Average True Range (ATR) | 0.15 | 0.09 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 72.52 | 7.59 |
Natural Alternatives International Inc is engaged in formulating, manufacturing, and marketing nutritional supplements. It offers vitamins, minerals, herbs, and other supplements, as well as other healthcare products to customers within the United States and internationally. Its business activity is operated through Private-Label Contract Manufacturing and Patent & Trademark Licensing segment. The company derives the majority of revenue from Private-Label Contract Manufacturing which is engaged in providing manufacturing services to companies that market and distribute nutritional supplements and other healthcare products, whereas the Patent and Trademark Licensing segment includes royalty income from its license and supply agreements associated with the sale.
The Glimpse Group Inc is a diversified immersive technology platform company, focused on providing enterprise solutions in virtual reality (VR), augmented reality (AR), and spatial computing. The company operates multiple subsidiaries that develop VR and AR software and services across various industries, including corporate training, education, healthcare, government, defense, marketing, retail, and financial services. It also offers AI-driven spatial computing platforms that support simulations, social VR, behavioral health, and corporate events. The Company reports its revenues in three categories: Software Services, Software License and Software-as-a-Service (SaaS), and Royalty Income, with the majority being from the Software Services category.